Workflow
Perfect(603059)
icon
Search documents
倍加洁:公司信息更新报告:主业增长稳健,参控股子公司加大投入拖累利润
KAIYUAN SECURITIES· 2024-09-01 07:40
隐证券 美容护理/个护用品 公 司 研 究 倍加洁(603059.SH) 2024 年 09 月 1 日 主业增长稳健,参控股子公司加大投入拖累利润 ——公司信息更新报告 投资评级:买入(维持) | --- | --- | |-------------------------|-------------| | 日期 | 2024/8/30 | | 当前股价 ( 元 ) | 19.77 | | 一年最高最低 ( 元 ) | 26.02/16.42 | | 总市值 ( 亿元 ) | 19.86 | | 流通市值 ( 亿元 ) | 19.86 | | 总股本 ( 亿股 ) | 1.00 | | 流通股本 ( 亿股 ) | 1.00 | | 近 3 个月换手率 (%) | 35.84 | 股价走势图 -30% -20% -10% 0% 10% 2023-08 2023-12 2024-04 倍加洁 沪深300 数据来源:聚源 相关研究报告 《Q1 需求恢复业绩迎拐点,期待大健 康领域业务表现—公司信息更新报 告》-2024.4.25 《拟出资控股微生物益生菌企业,成 长 性 可 期 — 公 司 信 息 更 新 报 告 ...
倍加洁(603059) - 2024 Q2 - 季度财报
2024-08-27 10:09
Financial Performance - The company's operating revenue for the first half of 2024 reached ¥620,160,522.82, representing a 28.60% increase compared to ¥482,250,410.36 in the same period last year[14]. - The net profit attributable to shareholders of the listed company was ¥33,142,878.09, a decrease of 9.36% from ¥36,566,884.05 in the previous year[14]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥31,482,910.36, down 13.09% from ¥36,223,421.87 in the same period last year[14]. - The net cash flow from operating activities was ¥65,410,112.97, an increase of 24.83% compared to ¥52,400,223.28 in the previous year[16]. - Basic earnings per share for the reporting period (January to June) decreased to 0.33 CNY, down 10.81% from 0.37 CNY in the same period last year[17]. - Diluted earnings per share also fell to 0.33 CNY, reflecting a 10.81% decline compared to the previous year[17]. - The weighted average return on equity decreased to 2.65%, down 0.44 percentage points from 3.09% year-on-year[17]. - The total comprehensive income for the first half of 2024 was ¥32,844,256.20, compared to ¥38,128,847.43 in the first half of 2023[83]. Market Overview - The oral hygiene product market in China is projected to grow at a compound annual growth rate of 3.75% from 2023 to 2028, following a slight decline in 2022 due to the pandemic[19]. - The market size for oral hygiene products in China was 491.5 billion CNY in 2023, recovering from a dip to 482 billion CNY in 2022[19]. - In the first half of 2024, the toothpaste market share reached 47.8%, while the toothbrush market share was 33.4%, together accounting for 81.2% of the oral care industry retail sales[20]. - The online retail sales of mouth spray products increased by 15% year-on-year in the first half of 2024, driven by rising consumer demand for personal image maintenance[20]. - The online retail sales of electric toothbrushes grew by 6.3% year-on-year in the first half of 2024, reflecting consumer preference for efficient cleaning and smart features[20]. Investment and Acquisitions - The company acquired a 52.0006% stake in Shan'enkang, which is now a subsidiary included in the consolidated financial statements[32]. - The company invested ¥6 million to establish a subsidiary in Hangzhou, named Hangzhou Yi Qin[39]. - The company acquired 1.59% equity in Wei Mei Zi for ¥2,531.47 million through a network auction[39]. - The company completed the acquisition of 52.0006% equity in Shen En Kang, which is now included in the consolidated financial statements[39]. Research and Development - The company has over 300 patents and a dedicated R&D team of more than 200 personnel, enhancing its innovation capabilities and industry influence[28]. - The company invested in R&D, with expenses increasing by 48.33% to ¥20,729,096.00, reflecting a commitment to innovation[32]. - The company has established two R&D centers for probiotic products, employing over 40 specialized researchers and holding numerous patents related to probiotics[29]. - The company reported a significant increase in research and development expenses, reflecting a focus on innovation[84]. Financial Position - The total assets at the end of the reporting period were ¥2,263,050,955.97, reflecting a 12.31% increase from ¥2,015,036,620.18 at the end of the previous year[16]. - The net assets attributable to shareholders of the listed company decreased by 11.21% to ¥1,109,064,345.42 from ¥1,249,089,661.23 at the end of the previous year[16]. - Cash and cash equivalents decreased by 14.57% to ¥59,902,878.08, primarily due to significant cash outflows from equity investments[35]. - Total liabilities increased to CNY 1,084,637,018.75 from CNY 765,946,958.95, indicating a growth of about 41.7%[77]. Risk Factors - The company has detailed potential risks in the report, which investors are advised to review[3]. - The company faces risks from fluctuations in raw material prices, particularly those linked to petrochemical products, which could impact profitability[48]. - The company is exposed to risks from market competition, particularly in the probiotics sector, where foreign brands dominate with an 85% market share[48]. - The company is actively expanding its overseas business but faces risks from exchange rate fluctuations and potential reductions in export tax rebate rates[49]. Corporate Governance - The company did not propose any profit distribution plan or capital reserve transfer to increase share capital during the reporting period[3]. - There were no non-operating fund occupations by controlling shareholders or other related parties during the reporting period[3]. - The company has established a knowledge property protection department to safeguard its core technologies and product formulas[49]. - The company has committed to not engaging in any competitive activities with its subsidiaries, ensuring no direct or indirect competition in the same business areas[57]. Compliance and Reporting - The company has maintained compliance with accounting standards, ensuring accurate financial reporting and transparency[99]. - The company has no significant doubts regarding its ability to continue as a going concern for the next 12 months[100]. - The company’s accounting policies are aligned with the relevant financial reporting standards, ensuring consistency in financial statements[101]. - The company follows a control-based approach for consolidating financial statements, including all subsidiaries under its control[107].
倍加洁:关于召开2024年第一次临时股东会的通知
2024-08-27 10:09
证券代码:603059 证券简称:倍加洁 公告编号:2024-035 倍加洁集团股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 一、 召开会议的基本情况 (一) 股东会类型和届次 2024 年第一次临时股东会 召开的日期时间:2024 年 9 月 12 日 14 点 30 分 召开地点:公司 8 号会议室 (五) 网络投票的系统、起止日期和投票时间。 股东会召开日期:2024年9月12日 本次股东会采用的网络投票系统:上海证券交易所股东大会网络投票系 统 (二) 股东会召集人:董事会 (三) 投票方式:本次股东会所采用的表决方式是现场投票和网络投票相结合 的方式 (四) 现场会议召开的日期、时间和地点 网络投票系统:上海证券交易所股东大会网络投票系统 关于召开 2024 年第一次临时股东会的通知 网络投票起止时间:自 2024 年 9 月 12 日 至 2024 年 9 月 12 日 采用上海证券交易所网络投票系统,通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段,即 9:15-9:2 ...
倍加洁:关于2024年半年度主要经营数据的公告
2024-08-27 10:07
证券代码:603059 证券简称:倍加洁 公告编号:2024-036 倍加洁集团股份有限公司 关于 2024 年半年度主要经营数据的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 倍加洁集团股份有限公司(以下简称"公司")根据《上海证券交易所上市 公司自律监管指引第 3 号——行业信息披露 第十三号 化工》有关规定,将公司 2024 年半年度主要经营数据披露如下: 二、主要产品和原材料的价格变动情况 (一)主要产品价格波动情况 单位:元/支、片 | 主要产品 | 2024 | 年半年度 | 2023 | 年半年度 | 变动幅度(%) | | | --- | --- | --- | --- | --- | --- | --- | | | | 均价 | | 均价 | | | | 牙刷 | | 1.177 | | | 1.245 | -5.46 | | 湿巾 | | 0.072 | | | 0.075 | -4.00 | (二)主要原材料价格波动情况 公司主要原材料有刷丝、塑料粒子、无纺布等。 1、刷丝 一、2024 年半年度 ...
倍加洁:倍加洁集团股份有限公司对外投资管理制度(2024年8月修订)
2024-08-27 10:07
第一章 总则 (七)委托理财; (八)其他投资。 倍加洁集团股份有限公司 对外投资管理制度 二零二四年八月修订 倍加洁集团股份有限公司 对外投资管理制度 本制度所称对外投资不包括公司购买原材料、设备和动力,以及出售 产品、商品等与日常经营相关的资产的行为。 1 第一条 为规范倍加洁集团股份有限公司(以下简称"公司")对外投资行为, 强化对外投资管理和监督,控制投资风险,提高投资效益,维护公司 及公司股东的合法利益,根据《中华人民共和国公司法》、《中华人民 共和国证券法》、《上海证券交易所股票上市规则》等有关法律法规、 规范性文件相关规定,结合《倍加洁集团股份有限公司章程》(以下 简称"《公司章程》")及公司实际情况,制定本制度。 第二条 本制度所称对外投资,是指公司为获取未来收益,以公司合法持有的 货币资金、实物、无形资产等资源进行的各种形式的投资活动,包括 但不限于下列行为: (一)新设立企业的股权投资; (二)新增投资企业的增资扩股、股权收购投资; (三)现有投资企业的增资扩股、股权收购投资; (四)公司经营性项目及资产投资; (五)股票、基金投资; (六)债券、委托贷款及其他债权投资; 第三条 本制度适 ...
倍加洁:倍加洁集团股份有限公司2023年年度权益分派实施公告
2024-07-08 09:08
证券代码:603059 证券简称:倍加洁 公告编号:2024-032 差异化分红送转: 否 一、 通过分配方案的股东大会届次和日期 倍加洁集团股份有限公司 2023 年年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 每股分配比例 A 股每股现金红利 0.2 元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权(息)日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | A股 | 2024/7/12 | - | 2024/7/15 | 2024/7/15 | 截至股权登记日下午上海证券交易所收市后,在中国证券登记结算有限责任公司上海分 公司(以下简称"中国结算上海分公司")登记在册的本公司全体股东。 3. 分配方案: 四、 分配实施办法 二、 分配方案 1. 实施办法 (1)无限售条件流通股的红利委托中国结算上海分公司通过其资金清算系统向股权登记 日上海证券交易所收市后登记在册并在上海证券交易所各会员办理了指定交易的股东派发。 已办理指 ...
倍加洁[.SH]2023年度暨2024年季度业绩说明会
第一财经研究院· 2024-06-11 17:02
Summary of the Earnings Call Company Overview - The earnings call is conducted by Beijiajie, discussing the performance for the year 2023 and the first quarter of 2024 [1] Key Points and Arguments - The meeting format includes video and text interaction, indicating a modern approach to investor communication [1] - The company expresses gratitude to the Shanghai Stock Exchange for providing the platform for this earnings call, highlighting the importance of regulatory support in investor relations [1] Other Important Content - The call aims to engage with investors and supporters, emphasizing the company's commitment to transparency and communication [1]
倍加洁:倍加洁关于召开2023年度暨2024年第一季度业绩说明会的公告
2024-05-30 10:26
倍加洁集团股份有限公司 关于召开 2023 年度暨 2024 年第一季度业绩说明会 的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 投资者可于 2024 年 06 月 03 日(星期一) 至 06 月 07 日(星期 五)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或 通过公司邮箱 bjjtg@oralstar.com 进行提问。公司将在说明会上对 投资者普遍关注的问题进行回答。 倍加洁集团股份有限公司(以下简称"公司")已于 2024 年 4 月 23 日发布公司 2023 年度报告及 2024 年第一季度报告,为便于广 大投资者更全面深入地了解公司 2023 年度及 2024 年第一季度经营 成果、财务状况,公司计划于 2024 年 06 月 11 日 下午 15:00- 16:30 举行 2023 年度暨 2024 年第一季度业绩说明会,就投资者关 心的问题进行交流。 会议召开时间:2024 年 06 月 11 日(星期二) 下午 15:00-16:30 会议召开地点:上海证券交易 ...
倍加洁:倍加洁关于全资子公司参与竞拍薇美姿实业(广东)股份有限公司1.59%股权进展的公告
2024-05-24 08:34
倍加洁集团股份有限公司 关于全资子公司参与竞拍薇美姿实业(广东)股份有限公司 1.59%股权进展的公告 证券代码:603059 证券简称:倍加洁 公告编号:2024-030 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、交易概述 倍加洁集团股份有限公司(以下简称"公司")于 2024 年 5 月 22 日召开第 三届董事会第十五次会议,审议通过了《关于全资子公司拟参与竞拍薇美姿实业 (广东)股份有限公司 1.59%股权的议案》,同意南京沄洁科技有限公司(以下 简称"南京沄洁")参与本次竞拍。具体内容详见公司于 2024 年 5 月 24 日在《中 国证券报》、《证券时报》及上海证券交易所网站披露的《倍加洁关于全资子公司 拟参与竞拍薇美姿实业(广东)股份有限公司 1.59%股权的公告》(公告编号: 2024-029)。 本次交易不构成关联交易,不构成《上市公司重大资产重组管理办法》规定 的重大资产重组。 二、竞拍结果 南京沄洁参与了广州市海珠区人民法院于 2024 年 5 月 23 日上午 10 时至 2024 年 5 月 ...
倍加洁近况交流
2024-05-24 04:24
Summary of Conference Call Company and Industry - The conference call is related to Pacific Pharmaceuticals, focusing on recent developments and updates in the company and its industry [1] Core Points and Arguments - The call welcomes participants and indicates that they are entering a transitional phase, suggesting a shift in company strategy or market conditions [1] Other Important but Possibly Overlooked Content - The call includes a formal statement and an introduction by the host, indicating a structured approach to the meeting [1]